OXIDATIVE STRESS AS A CAUSE OF PARKINSONS-DISEASE

被引:173
作者
JENNER, P
机构
[1] Parkinson's Disease Society Experimental Research Laboratories, King's College London, London
[2] Pharmacology Group, Biomedical Sciences Division, King's College London, London, SW3 6LX, Manresa Road
来源
ACTA NEUROLOGICA SCANDINAVICA | 1991年 / 84卷
关键词
PARKINSONS DISEASE; MPTP; IRON LEVELS; MITOCHONDRIAL FUNCTION; OXIDATIVE STRESS;
D O I
10.1111/j.1600-0404.1991.tb05013.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The cause of dopamine cell death in Parkinson's disease remains unknown. Present interest centres on the possible involvement of a toxin mediated mechanism such as that produced, by MPTP. In post-mortem studies there is evidence in the substantia nigra for an on-going toxic process involving increased lipid peroxidation, altered iron metabolism and impairment of mitochondrial function at the level of complex I. Although the precise relationship between these biochemical changes is not known, present evidence points to oxidative stress as an important factor contributing to neuronal loss. Altered mitochondrial function and increased iron levels may not initiate Parkinson's disease but rather act to accelerate cell death. Future strategies for the treatment of Parkinson's disease should be aimed at preventing oxidative stress and stopping or slowing the progression of the underlying pathology.
引用
收藏
页码:6 / 15
页数:10
相关论文
共 91 条
[21]   STUDIES ON PARKINSONS DISEASE INCLUDING X-RAY FLUORESCENT SPECTROSCOPY OF FORMALIN FIXED BRAIN TISSUE [J].
EARLE, KM .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1968, 27 (01) :1-+
[22]   TRANSIENT NIGRAL UBIQUINONE DEPLETION AFTER SINGLE MPTP ADMINISTRATION IN MICE [J].
FARIELLO, RG ;
GHIRARDI, O ;
PESCHECHERA, A ;
RAMACCI, MT ;
ANGELUCCI, L .
NEUROPHARMACOLOGY, 1987, 26 (12) :1799-1802
[23]  
FEARNLEY JM, 1991, IN PRESS BRAIN
[24]   EFFECT OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) ON LEVELS OF GLUTATHIONE IN THE EXTRAPYRAMIDAL SYSTEM OF THE MOUSE [J].
FERRARO, TN ;
GOLDEN, GT ;
DEMATTEI, M ;
HARE, TA ;
FARIELLO, RG .
NEUROPHARMACOLOGY, 1986, 25 (09) :1071-1074
[25]  
FINNEGAN KT, 1984, EUR J PHARMACOL, P119
[26]   MODEL STUDY ON THE BIOREDUCTION OF PARAQUAT, MPP+, AND ANALOGS - EVIDENCE AGAINST A REDOX CYCLING MECHANISM IN MPTP NEUROTOXICITY [J].
FRANK, DM ;
ARORA, PK ;
BLUMER, JL ;
SAYRE, LM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 147 (03) :1095-1104
[27]   1-METHYL-4-PHENYLPYRIDINIUM (MPP+) INDUCES NADH-DEPENDENT SUPEROXIDE FORMATION AND ENHANCES NADH-DEPENDENT LIPID-PEROXIDATION IN BOVINE HEART SUBMITOCHONDRIAL PARTICLES [J].
HASEGAWA, E ;
TAKESHIGE, K ;
OISHI, T ;
MURAI, Y ;
MINAKAMI, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 170 (03) :1049-1055
[28]   STUDIES ON THE OXIDATION OF THE DOPAMINERGIC NEUROTOXIN 1-METHYL-4-PHENYL-1,2,5,6-TETRAHYDROPYRIDINE BY MONOAMINE OXIDASE-B [J].
HEIKKILA, RE ;
MANZINO, L ;
CABBAT, FS ;
DUVOISIN, RC .
JOURNAL OF NEUROCHEMISTRY, 1985, 45 (04) :1049-1054
[29]  
HEIKKILA RE, 1984, NATURE, V311, P467, DOI 10.1038/311467a0
[30]   IRON AND ALUMINUM INCREASE IN THE SUBSTANTIA-NIGRA OF PATIENTS WITH PARKINSONS-DISEASE - AN X-RAY-MICROANALYSIS [J].
HIRSCH, EC ;
BRANDEL, JP ;
GALLE, P ;
JAVOYAGID, F ;
AGID, Y .
JOURNAL OF NEUROCHEMISTRY, 1991, 56 (02) :446-451